WuXi AppTec - Asia Tech Wire

WuXi AppTec

2025.01.24

10:31

The Hong Kong stock market's biotechnology sector rose and strengthened, with WuXi AppTec (02359.HK) rising more than 5%, CanSino Biologics (06185.HK) rising more than 4%, and many stocks including Tiger Pharmaceuticals (03347.HK) and Junshi Biosciences (01877.HK) following suit.

2025.01.20

16:12

At the close of Hong Kong stocks, the Hang Seng Index closed up 1.75%, the Hang Seng Tech Index closed up 2.59%, WuXi AppTec (02359.HK) closed up 7.23%, and JD.com (09618.HK) closed up 7.29%.

16:10

Hong Kong stocks closed: Hang Seng Index rose 1.75% Hang Seng Technology Index rose 2.59%

At the close of Hong Kong stocks, the Hang Seng Index rose 1.75%, and the Hang Seng Technology Index rose 2.59%. The pharmaceutical sector led the gains, with WuXi AppTec and JD.com rising more than 7%, Meituan and Vanke rising more than 5%, and Alibaba rising more than 4%.

12:01

Hong Kong Stocks Midday Review: Hang Seng Index rose 2.33% and Hang Seng Technology Index rose 3.17%

At the close of Hong Kong stocks at noon, the Hang Seng Index rose 2.33% and the Hang Seng Technology Index rose 3.17%. Pharmaceutical stocks led the gains, with JD.com and WuXi AppTec rising more than 7%, Alibaba and Meituan rising more than 6%, and WuXi Biologics rising more than 5%.

09:44

Hong Kong-listed pharmaceutical stocks strengthened, with WuXi AppTec rising more than 5%

Hong Kong-listed pharmaceutical stocks strengthened, with WuXi AppTec rising more than 5%, followed by WuXi Biologics, CStone Pharmaceuticals, Corning Life Sciences, and Tigermed.

09:36

The Hong Kong stock biopharmaceutical sector rose in early trading, with WuXi AppTec (02359.HK) rising more than 5%, WuXi Biologics (02269.HK) rising more than 4%, BeiGene (06160.HK), Tiger Pharmaceuticals (03347.HK) and others following suit.

2025.01.14

17:22

JPMorgan Chase's long position in WuXi AppTec's H shares fell from 10.57% to 9.46% on January 8

Hong Kong Stock Exchange documents show that JPMorgan's long position in WuXi AppTec's H shares fell from 10.57% to 9.46% on January 8.

2025.01.13

17:30

Hong Kong Stock Exchange documents show that Citigroup's long position in WuXi AppTec's H shares fell to 4.11% on January 7, from 5.05% previously.

17:22

Hong Kong Stock Exchange documents show that JPMorgan's short position in WuXi AppTec's H shares increased to 4.99% on January 7, from 3.64% previously.

17:07

WuXi AppTec: Sold 7.17% of WuXi Helian shares, achieving cumulative investment income of RMB 2.016 billion

WuXi AppTec announced that the company has sold a total of 86 million shares of WuXi Helian through its indirect holding subsidiaries, accounting for approximately 7.17% of WuXi Helian's current total share capital, with a total transaction amount of approximately HK$2.426 billion, accounting for 4.07% of the company's latest audited net assets attributable to the parent company's shareholders. According to preliminary calculations, the company's cumulative investment income from the sale of WuXi Helian shares in the past twelve months was RMB 2.016 billion, accounting for more than 10% of the company's latest audited net profit attributable to the parent company's shareholders, of which the impact on the company's current net profit in 2024 was approximately RMB 720 million, and the impact on the company's current net profit in 2025 was approximately RMB 1.297 billion.

2025.01.09

10:03

Hong Kong stocks related to pharmaceutical outsourcing concepts collectively strengthened, with WuXi Biologics (02269.HK) rising more than 4%, WuXi AppTec (02359.HK) rising more than 2%, Zhaoyan Pharmaceutical (06127.HK) and Tiger Pharmaceuticals (03347.HK) rising more than 1%.

2025.01.07

10:04

Hong Kong-listed pharmaceutical stocks fell, with Shandong Xinhua Pharmaceutical falling more than 5%

Hong Kong-listed pharmaceutical stocks fell, with Shandong Xinhua Pharmaceutical falling more than 5%, WuXi Biologics falling more than 4%, and WuXi AppTec, BeiGene, Junshi Biosciences and others following suit.

2025.01.02

17:29

According to Hong Kong Stock Exchange documents, as of December 27, BlackRock reduced its long position in WuXi AppTec (02359.HK) H shares from 6.01% to 5.33%.

2024.12.30

16:12

At the close of Hong Kong stocks, the Hang Seng Index closed down 0.24%, and the Tech Index closed down 0.84%; SMIC (00981.HK) rose more than 6%, WuXi AppTec (02359.HK) rose more than 5%, and Oriental Selection (01797.HK) rose more than 4%; Haidilao (06862.HK) and Xpeng Motors (09868.HK) both fell more than 5%.

16:10

Hong Kong stocks closed: Hang Seng Index closed down 0.24% Hang Seng Technology Index closed down 0.84%

At the close of Hong Kong stocks, the Hang Seng Index closed down 0.24%, and the Hang Seng Technology Index closed down 0.84%. Semiconductor and pharmaceutical sectors led the gains, with SMIC up more than 6% and WuXi AppTec up more than 5%; UBTECH fell more than 30% and Xpeng Motors fell more than 5%.

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Southwest Airlines CEO: Although Boeing still has a lot of work to do, they seem to be moving in a good direction and we are more optimistic.
                            2025-01-31

                                    White House Press Secretary Levitt: Details about the Nvidia meeting are still unclear.
                            2025-02-01

                                    Apple (AAPL.O) said the Apple Pay outage has been resolved.
                            2025-01-29

                                    Jefferies: Raised Meta Platforms (META.O) price target from $715 to $810.
                            2025-01-30

                                    Sam Altman, founder and CEO of OpenAI: OpenAI will develop specialized hardware for AI.
                            2025-02-03